Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05767788
Other study ID # MWMKOA
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date December 10, 2022
Est. completion date May 10, 2023

Study information

Verified date January 2023
Source The Hong Kong Polytechnic University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Movement with mobilization (MWM) is an effective manual therapy to improve pain and function of patients with knee osteoarthritis (OA). However, immediate, and prolonged effects after prolonged MWM period was under-investigated. In this double-blinded randomized control trial, 40 patients are needed. The subjects and assessors will be blinded. Subjects in intervention group will receive MWM twice a week and corresponding home exercise for 6 weeks. Participants in control group will only receive sham treatment with light touch. The effects on knee pain in visual analogue scale (VAS); flexion and extension range of motion (ROM) by goniometer; strength by hand-held dynamometer; function by Timed Up and Go Test (TUG) and 30-second Chair Stand Test; and health-related quality of life (HRQoL) by Knee Injury and Osteoarthritis Outcome Score (KOOS) and Western Ontario and McMaster Universities Arthritis Index (WOMAC) just after, 1-month and 3-month after treatment will be compared with baseline. Six-month after treatment, KOOS and WOMAC will be conducted.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 40
Est. completion date May 10, 2023
Est. primary completion date May 10, 2023
Accepts healthy volunteers No
Gender All
Age group 40 Years and older
Eligibility Inclusion Criteria: - History of knee OA for at least 1-year - Pain intensity level = 3 on a 10-cm Visual Analogue Scale (VAS) - Both unilateral or bilateral knee pain - Having morning stiffness less than 30 minutes - Having crepitus on active movement - Having bony tenderness - Having bony enlargement Exclusion Criteria: - Having active inflammatory or infectious knee conditions - Having bone integrity conditions like osteoporosis - Having knee joint instability - Having skin integrity conditions like frail skin or lower limb peripheral vascular disease - History of hip or knee fracture - History of knee surgical history - Use of knee corticosteroid or opioid injection

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Movement with Mobilization (MWM)
Painful active functional knee movement is identified. The most comfortable passive medial, lateral, medial rotatory, lateral rotatory, postero-anterior, and antero-posterior glide, is applied to the knee of the patient. Three sets of 10 repetitions are applied. Corresponding home MWM exercise is taught. The treatment is conducted for 12 sessions over 6 weeks.
Sham Movement with Mobilization (Sham MWM)
Painful active functional knee movement is identified. The most comfortable passive medial, lateral, medial rotatory, lateral rotatory, postero-anterior, and antero-posterior light-touch glide, is applied to the knee of the patient. Three sets of 10 repetitions are applied. Corresponding home MWM exercise is taught. The treatment is conducted for 12 sessions over 6 weeks.

Locations

Country Name City State
Hong Kong Department of Rehabilitation Sciences, The Hong Kong Polytechnic University Hong Kong

Sponsors (1)

Lead Sponsor Collaborator
The Hong Kong Polytechnic University

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change of pain in the Visual Analogue Scale (VAS) Subjects will indicate the pain level on a 100-millimeter line with endpoints, marked "no pain" and "worst imaginable pain", at the time of assessment. The change before the start of treatment and after 6-week treatment
Primary Change of pain in the Visual Analogue Scale (VAS) Subjects will indicate the pain level on a 100-millimeter line with endpoints, marked "no pain" and "worst imaginable pain", at the time of assessment. The change before the start of treatment and 1-month after last treatment session
Primary Change of pain in the Visual Analogue Scale (VAS) Subjects will indicate the pain level on a 100-millimeter line with endpoints, marked "no pain" and "worst imaginable pain", at the time of assessment. The change before the start of treatment and 3-month after last treatment session
Secondary Change of time used in the Timed Up and Go Test (TUG) Subjects will be instructed to get up from the chair and then walk to a target 3 meters away, turn around, walk back to the chair, and sit down. The time used will be recorded. An average of two testing trials will be used. The change before the start of treatment and after 6-week treatment
Secondary Change of time used in the Timed Up and Go Test (TUG) Subjects will be instructed to get up from the chair and then walk to a target 3 meters away, turn around, walk back to the chair, and sit down. The time used will be recorded. An average of two testing trials will be used. The change before the start of treatment and 1-month after last treatment session
Secondary Change of time used in the Timed Up and Go Test (TUG) Subjects will be instructed to get up from the chair and then walk to a target 3 meters away, turn around, walk back to the chair, and sit down. The time used will be recorded. An average of two testing trials will be used. The change before the start of treatment and 3-month after last treatment session
Secondary Change of number of repetitions in the 30-second Chair Stand Test (30CST) Subjects will be instructed to stand up from the chair and then return to sit down on the chair repeatedly for 30 seconds or until the subject fails to continue at any time point during the trial. Only 1 testing trial will be used. The change before the start of treatment and after 6-week treatment
Secondary Change of number of repetitions in the 30-second Chair Stand Test (30CST) Subjects will be instructed to stand up from the chair and then return to sit down on the chair repeatedly for 30 seconds or until the subject fails to continue at any time point during the trial. Only 1 testing trial will be used. The change before the start of treatment and 1-month after last treatment session
Secondary Change of number of repetitions in the 30-second Chair Stand Test (30CST) Subjects will be instructed to stand up from the chair and then return to sit down on the chair repeatedly for 30 seconds or until the subject fails to continue at any time point during the trial. Only 1 testing trial will be used. The change before the start of treatment and 3-month after last treatment session
Secondary Change of knee flexors muscle strength by the hand-held dynamometer A digital dynamometer will be used to measure the muscle strength (in kilograms) of the subject's hamstrings muscles. Subjects will be guided to sit with their arms crossed at the shoulders and hold against their chest, back straight, knees relax in 90 degrees flexion in a high sitting position. The isometric peak force for flexion will be recorded respectively.
An average of 3 testing trials will be used.
The change before the start of treatment and after 6-week treatment
Secondary Change of knee flexors muscle strength by the hand-held dynamometer A digital dynamometer will be used to measure the muscle strength (in kilograms) of the subject's hamstrings muscles. Subjects will be guided to sit with their arms crossed at the shoulders and hold against their chest, back straight, knees relax in 90 degrees flexion in a high sitting position. The isometric peak force for flexion will be recorded respectively.
An average of 3 testing trials will be used.
The change before the start of treatment and 1-month after last treatment session
Secondary Change of knee flexors muscle strength by the hand-held dynamometer A digital dynamometer will be used to measure the muscle strength (in kilograms) of the subject's hamstrings muscles. Subjects will be guided to sit with their arms crossed at the shoulders and hold against their chest, back straight, knees relax in 90 degrees flexion in a high sitting position. The isometric peak force for flexion will be recorded respectively.
An average of 3 testing trials will be used.
The change before the start of treatment and 3-month after last treatment session
Secondary Change of knee extensors muscle strength by the hand-held dynamometer A digital dynamometer will be used to measure the muscle strength (in kilograms) of the subject's quadriceps and muscles.
Subjects will be guided to sit with their arms crossed at the shoulders and hold against their chest, back straight, knees relax in 90 degrees flexion in a high sitting position.
The isometric peak force for flexion and extension will be recorded respectively.
An average of 3 testing trials will be used.
The change before the start of treatment and after 6-week treatment
Secondary Change of knee extensors muscle strength by the hand-held dynamometer A digital dynamometer will be used to measure the muscle strength (in kilograms) of the subject's quadriceps and muscles.
Subjects will be guided to sit with their arms crossed at the shoulders and hold against their chest, back straight, knees relax in 90 degrees flexion in a high sitting position.
The isometric peak force for flexion and extension will be recorded respectively.
An average of 3 testing trials will be used.
The change before the start of treatment and 1-month after last treatment session
Secondary Change of knee extensors muscle strength by the hand-held dynamometer A digital dynamometer will be used to measure the muscle strength (in kilograms) of the subject's quadriceps and muscles.
Subjects will be guided to sit with their arms crossed at the shoulders and hold against their chest, back straight, knees relax in 90 degrees flexion in a high sitting position.
The isometric peak force for flexion and extension will be recorded respectively.
An average of 3 testing trials will be used.
The change before the start of treatment and 3-month after last treatment session
Secondary Change of score of the Knee Injury and Osteoarthritis Outcome Score (KOOS) A health-related quality of life questionnaire. The score ranges from 0% (the worst) to 100% (the best). The change before the start of treatment and after 6-week treatment
Secondary Change of score of the Knee Injury and Osteoarthritis Outcome Score (KOOS) A health-related quality of life questionnaire. The score ranges from 0% (the worst) to 100% (the best). The change before the start of treatment and 1-month after last treatment session
Secondary Change of score of the Knee Injury and Osteoarthritis Outcome Score (KOOS) A health-related quality of life questionnaire. The score ranges from 0% (the worst) to 100% (the best). The change before the start of treatment and 3-month after last treatment session
Secondary Change of score of the Knee Injury and Osteoarthritis Outcome Score (KOOS) A health-related quality of life questionnaire. The score ranges from 0% (the worst) to 100% (the best). The change before the start of treatment and 6-month after last treatment session
Secondary Change of score of the Western Ontario and McMaster Universities Arthritis Index (WOMAC) A health-related quality of life questionnaire. The score ranges from 0 (the worst) to 100 (the best). The change before the start of treatment and after 6-week treatment
Secondary Change of score of the Western Ontario and McMaster Universities Arthritis Index (WOMAC) A health-related quality of life questionnaire. The score ranges from 0 (the worst) to 100 (the best). The change before the start of treatment and 1-month after last treatment session
Secondary Change of score of the Western Ontario and McMaster Universities Arthritis Index (WOMAC) A health-related quality of life questionnaire. The score ranges from 0 (the worst) to 100 (the best). The change before the start of treatment and 3-month after last treatment session
Secondary Change of score of the Western Ontario and McMaster Universities Arthritis Index (WOMAC) A health-related quality of life questionnaire. The score ranges from 0 (the worst) to 100 (the best). The change before the start of treatment and 6-month after last treatment session
Secondary Change of active knee flexion range of motion by the standard goniometer The active range of motion for knee flexion will be measured with a standard goniometer on the painful knee in supine.
An average of 3 testing trials will be used.
The change before the start of treatment and after 6-week treatment
Secondary Change of active knee flexion range of motion by the standard goniometer The active range of motion for knee flexion will be measured with a standard goniometer on the painful knee in supine.
An average of 3 testing trials will be used.
The change before the start of treatment and 1-month after last treatment session
Secondary Change of active knee flexion range of motion by the standard goniometer The active range of motion for knee flexion will be measured with a standard goniometer on the painful knee in supine.
An average of 3 testing trials will be used.
The change before the start of treatment and 3-month after last treatment session
Secondary Change of active knee extension range of motion by the standard goniometer The active range of motion for knee flexion will be measured with a standard goniometer on the painful knee in supine.
An average of 3 testing trials will be used.
The change before the start of treatment and after 6-week treatment
Secondary Change of active knee extension range of motion by the standard goniometer The active range of motion for knee flexion will be measured with a standard goniometer on the painful knee in supine.
An average of 3 testing trials will be used.
The change before the start of treatment and 1-month after last treatment session
Secondary Change of active knee extension range of motion by the standard goniometer The active range of motion for knee flexion will be measured with a standard goniometer on the painful knee in supine.
An average of 3 testing trials will be used.
The change before the start of treatment and 3-month after last treatment session
See also
  Status Clinical Trial Phase
Recruiting NCT04651673 - Prescribed Knee Brace Treatments for Osteoarthritis of the Knee (Knee OA)
Completed NCT05677399 - Knee Osteoarthritis Treatment With Peloidotherapy and Aquatic Exercise. N/A
Active, not recruiting NCT04043819 - Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis Phase 1
Recruiting NCT06000410 - A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee Phase 3
Completed NCT05014542 - Needling Techniques for Knee Osteoarthritis N/A
Recruiting NCT05892133 - Prehabilitation Effect on Function and Patient Satisfaction Following Total Knee Arthroplasty N/A
Recruiting NCT05528965 - Parallel Versus Perpendicular Technique for Genicular Radiofrequency N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Active, not recruiting NCT02003976 - A Randomized Trial Comparing High Tibial Osteotomy Plus Non-Surgical Treatment and Non-Surgical Treatment Alone N/A
Active, not recruiting NCT04017533 - Stability of Uncemented Medially Stabilized TKA N/A
Completed NCT04779164 - The Relation Between Abdominal Obesity, Type 2 Diabetes Mellitus and Knee Osteoarthritis N/A
Recruiting NCT04006314 - Platelet Rich Plasma and Neural Prolotherapy Injections in Treating Knee Osteoarthritis N/A
Recruiting NCT05423587 - Genicular Artery Embolisation for Knee Osteoarthritis II N/A
Enrolling by invitation NCT04145401 - Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK
Active, not recruiting NCT03781843 - Effects of Genicular Nerve Block in Knee Osteoarthritis N/A
Recruiting NCT05974501 - Pre vs Post Block in Total Knee Arthroplasty (TKA) Phase 4
Completed NCT05324163 - Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis Phase 3
Completed NCT05529914 - Effects of Myofascial Release and Neuromuscular Training for Pes Anserine Syndrome Associated With Knee Osteoarthritis N/A
Recruiting NCT05693493 - Can Proprioceptive Knee Brace Improve Functional Outcome Following TKA? N/A
Not yet recruiting NCT05510648 - Evaluation of the Effect of High-intensity Laser Therapy in Knee Osteoarthritis N/A